Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review

BACKGROUND: Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) is classified as group 3 pulmonary hypertension. Inhaled treprostinil, a prostaglandin I(2) analogue also known as prostacyclin, has recently been approved as a first drug for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqarni, Abdullah A., Aldhahir, Abdulelah M., Bintalib, Heba M., Alqahtani, Jaber S., Siraj, Rayan A., Majrshi, Mansour, AlGarni, Abdulkareem A., Naser, Abdallah Y., Alghamdi, Sara A., Alwafi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496018/
https://www.ncbi.nlm.nih.gov/pubmed/37706024
http://dx.doi.org/10.3389/fmed.2023.1217156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496018/
https://www.ncbi.nlm.nih.gov/pubmed/37706024
http://dx.doi.org/10.3389/fmed.2023.1217156

Ejemplares similares